ID   FEM1A_RAT               Reviewed;         654 AA.
AC   Q4V890;
DT   18-MAR-2008, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2005, sequence version 1.
DT   24-JUL-2024, entry version 119.
DE   RecName: Full=Protein fem-1 homolog A {ECO:0000305};
DE            Short=FEM1a {ECO:0000305};
DE   AltName: Full=FEM1-alpha {ECO:0000305};
GN   Name=Fem1a {ECO:0000312|RGD:1561112};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Substrate-recognition component of a Cul2-RING (CRL2) E3
CC       ubiquitin-protein ligase complex of the DesCEND (destruction via C-end
CC       degrons) pathway, which recognizes a C-degron located at the extreme C
CC       terminus of target proteins, leading to their ubiquitination and
CC       degradation. The C-degron recognized by the DesCEND pathway is usually
CC       a motif of less than ten residues and can be present in full-length
CC       proteins, truncated proteins or proteolytically cleaved forms. The
CC       CRL2(FEM1A) complex specifically recognizes proteins with an arginine
CC       at the C-terminus: recognizes and binds proteins ending with -Lys/Arg-
CC       Xaa-Arg and -Lys/Arg-Xaa-Xaa-Arg C-degrons, such as SIL1 or OR51B2,
CC       leading to their ubiquitination and degradation (By similarity).
CC       Involved in PGE2-EP4-mediated inhibition of inflammation of macrophages
CC       via interaction with NFKB1 and PTGER4. Promotes inflammation in brain
CC       microglia through MAP2K4/MKK4-mediated signaling (By similarity).
CC       {ECO:0000250|UniProtKB:Q9BSK4, ECO:0000250|UniProtKB:Q9Z2G1}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000250|UniProtKB:Q9BSK4}.
CC   -!- SUBUNIT: Component of a CRL2 E3 ubiquitin-protein ligase complex, also
CC       named ECS (Elongin BC-CUL2/5-SOCS-box protein) complex, composed of
CC       CUL2, Elongin BC (ELOB and ELOC), RBX1 and substrate-specific adapter
CC       FEM1A. Interacts with PTGER4 (By similarity). Interacts with NFKB1; the
CC       interaction is direct (By similarity). {ECO:0000250|UniProtKB:Q9BSK4,
CC       ECO:0000250|UniProtKB:Q9Z2G1}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000250|UniProtKB:Q9BSK4}.
CC       Cytoplasm {ECO:0000250|UniProtKB:Q9BSK4}.
CC   -!- PTM: Phosphorylated; highly phosphorylated in myoblasts and myotubes.
CC       Phosphorylation at Ser-108 and Ser-608 promote PGE2-EP4-mediated
CC       inhibition of inflammation. Dephosphorylated by protein phosphatase 2A
CC       (PP2A). {ECO:0000250|UniProtKB:Q9Z2G1}.
CC   -!- SIMILARITY: Belongs to the fem-1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC097490; AAH97490.1; -; mRNA.
DR   RefSeq; NP_001020877.1; NM_001025706.1.
DR   AlphaFoldDB; Q4V890; -.
DR   SMR; Q4V890; -.
DR   STRING; 10116.ENSRNOP00000067295; -.
DR   iPTMnet; Q4V890; -.
DR   PhosphoSitePlus; Q4V890; -.
DR   jPOST; Q4V890; -.
DR   PaxDb; 10116-ENSRNOP00000067295; -.
DR   Ensembl; ENSRNOT00000099590.1; ENSRNOP00000091315.1; ENSRNOG00000066151.1.
DR   Ensembl; ENSRNOT00055026060; ENSRNOP00055021222; ENSRNOG00055015251.
DR   Ensembl; ENSRNOT00060033378; ENSRNOP00060027311; ENSRNOG00060019318.
DR   Ensembl; ENSRNOT00065022434; ENSRNOP00065017393; ENSRNOG00065013637.
DR   GeneID; 316131; -.
DR   KEGG; rno:316131; -.
DR   AGR; RGD:1561112; -.
DR   CTD; 55527; -.
DR   RGD; 1561112; Fem1a.
DR   eggNOG; KOG0508; Eukaryota.
DR   GeneTree; ENSGT00940000161210; -.
DR   HOGENOM; CLU_020042_2_0_1; -.
DR   InParanoid; Q4V890; -.
DR   OMA; MMQPFNY; -.
DR   OrthoDB; 1063832at2759; -.
DR   PhylomeDB; Q4V890; -.
DR   Reactome; R-RNO-8951664; Neddylation.
DR   UniPathway; UPA00143; -.
DR   PRO; PR:Q4V890; -.
DR   Proteomes; UP000002494; Chromosome 9.
DR   Bgee; ENSRNOG00000050646; Expressed in skeletal muscle tissue and 19 other cell types or tissues.
DR   GO; GO:0031462; C:Cul2-RING ubiquitin ligase complex; ISS:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; ISS:UniProtKB.
DR   GO; GO:0000151; C:ubiquitin ligase complex; IBA:GO_Central.
DR   GO; GO:0031867; F:EP4 subtype prostaglandin E2 receptor binding; ISO:RGD.
DR   GO; GO:1990756; F:ubiquitin-like ligase-substrate adaptor activity; ISS:UniProtKB.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; ISO:RGD.
DR   GO; GO:0050729; P:positive regulation of inflammatory response; ISS:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway.
DR   GO; GO:0051438; P:regulation of ubiquitin-protein transferase activity; ISS:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR   GO; GO:0140627; P:ubiquitin-dependent protein catabolic process via the C-end degron rule pathway; ISS:UniProtKB.
DR   Gene3D; 1.25.40.20; Ankyrin repeat-containing domain; 3.
DR   Gene3D; 1.25.40.10; Tetratricopeptide repeat domain; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR050842; CRL2_E3_Ligase_Fem-1.
DR   InterPro; IPR011990; TPR-like_helical_dom_sf.
DR   PANTHER; PTHR24173; ANKYRIN REPEAT CONTAINING; 1.
DR   PANTHER; PTHR24173:SF74; UVEAL AUTOANTIGEN WITH COILED-COIL DOMAINS AND ANKYRIN REPEATS; 1.
DR   Pfam; PF00023; Ank; 1.
DR   Pfam; PF12796; Ank_2; 3.
DR   PRINTS; PR01415; ANKYRIN.
DR   SMART; SM00248; ANK; 9.
DR   SUPFAM; SSF48403; Ankyrin repeat; 2.
DR   SUPFAM; SSF48452; TPR-like; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 2.
DR   PROSITE; PS50088; ANK_REPEAT; 7.
PE   2: Evidence at transcript level;
KW   ANK repeat; Cytoplasm; Mitochondrion; Phosphoprotein; Reference proteome;
KW   Repeat; TPR repeat; Ubl conjugation pathway.
FT   CHAIN           1..654
FT                   /note="Protein fem-1 homolog A"
FT                   /id="PRO_0000324528"
FT   REPEAT          2..31
FT                   /note="ANK 1"
FT   REPEAT          40..70
FT                   /note="ANK 2"
FT   REPEAT          82..111
FT                   /note="ANK 3"
FT   REPEAT          115..145
FT                   /note="ANK 4"
FT   REPEAT          149..178
FT                   /note="ANK 5"
FT   REPEAT          182..211
FT                   /note="ANK 6"
FT   REPEAT          214..243
FT                   /note="ANK 7"
FT   REPEAT          283..317
FT                   /note="TPR 1"
FT   REPEAT          375..408
FT                   /note="TPR 2"
FT   REPEAT          519..561
FT                   /note="ANK 8"
FT   REPEAT          565..594
FT                   /note="ANK 9"
FT   REGION          241..265
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        241..262
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         108
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z2G1"
FT   MOD_RES         608
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z2G1"
SQ   SEQUENCE   654 AA;  72118 MW;  DE3BFC58447C37C2 CRC64;
     MDLHTAVYNA AHDGKLLLLQ KLLAGRGREE IEELLGEVAG GGTPLLIAAR RGHLDVVEYL
     VDNCGASVEA SGSVHFDGET IEGAPPLWAA SAAGHLAVVR SLLRRGASVN RTTRTNSTPL
     RAACFDGHLD VVRYLVGEHK ADLEVANRHG HTCLMISCYK GHREIARYLL ERGAQVNRRS
     AKGNTALHDC AESGSLEILQ LLLGCHARME RDGYGMTPLL AASVTGHTNI VEYLIQEQPG
     HGQLSGTELP GEGSSQMAGN HCSTPEEAEP YESCCPTSRE AAVEALELLG ATYVDKKRDL
     LGALKHWRRA MELRHQGGDY LPKPEPQQLV LAYDYSREVS TPQELEALIT DPDEMRMQAL
     LIRERILGPS HPDTSYYIRY RGAVYADSGN FERCIRLWKY ALDMQQNNLE PLSPMTASSF
     LSFAELFSYV LQDRSAKGNL GMQLGFADLM GVLSKGVREV ERALQLPKEP GDSAQFTKAI
     AIILHLLYLL EKVECTPSQE HLKHQTVYRL LKCAPRGKNG FTPLHMAVDK ETTNVGRYRV
     GIFPSLQVVK VLLDCGADPD SRDFDNNTPL HVAAQNNCPA IMDALIEAGA HMDATNAFKK
     TAYELLDSKL LAKSTMQPFN YVTLQCLAAR ALDRNKVPYK GFIPEELEAF IQLH
//
